IGF-1 is an independent risk factor for anemia in diabetic pre-dialysis patients

Do Hyoung Kim, Tae Young Kim, Sun Min Kim, Soo Jeong Yoo, Dong Jin Oh, Suk Hee Yu

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background: We investigated whether the presence of diabetes mellitus (DM) was related to the degree of the anemia in predialytic patients with renal failure and what was the most relevant factor for anemia in patients with chronic kidney disease (CKD) from DM (DM-CKD). Methods: Seventy seven patients (47 predialytic patients with long-term type 2 DM (DM-CKD) and 30 predialytic patients whose disease was due to other causes (non DM-CKD)) were enrolled in this study. The blood hemoglobin (Hb) and hematocrit, and the creatinine, ferritin, vitamin B12, folate, iron, LDH, albumin, hs-CRP, intact-PTH, erythropoietin, leptin and Insulin-like growth factor I (IGF-1) levels were measured using standard methods. The estimated GFR was calculated using the abbreviated MDRD equation. Results: The two groups did not significantly differ as to age, gender, the serum creatinine level and the inflammatory status. The Hb level was significantly lower in the DM-CKD patients than that in the non DM-CKD patients (8.5±1.7 g/dL vs 9.6±1.6 g/dL, respectively, p=0.01). The Hb level was significantly lower in the DM-CKD patients who were being treated with ACE inhibitors (the DM-ACE patients) than that in the non DM-CKD patients who were being treated with ACE inhibitors (the non DM-ACE patients) (8.5±1.5 g/dL vs 10.8±1.6 g/dL, respectively, p=0.001). Multiple regression analysis indicated that serum IGF-1 concentration was independently associated with the Hb level (β=0.425, p=0.02) in the DM-CKD patients. Conclusions: The Hb concentration was significantly lower in the DM-CKD patients than that in the non DM-CKD patients. It was independently associated with the serum IGF-1 concentration in the DM-CKD patients.

Original languageEnglish
Pages (from-to)186-191
Number of pages6
JournalKorean Journal of Internal Medicine
Volume22
Issue number3
DOIs
StatePublished - 2007 Jan 1

Fingerprint

Insulin-Like Growth Factor I
Anemia
Dialysis
Diabetes Mellitus
Chronic Renal Insufficiency
Hemoglobins
Angiotensin-Converting Enzyme Inhibitors
Creatinine
Serum
Vitamin B 12
Ferritins
Erythropoietin
Leptin
Hematocrit
Folic Acid
Type 2 Diabetes Mellitus
Renal Insufficiency
Albumins
Iron

Keywords

  • ACE inhibitor
  • Anemia
  • Diabetes mellitus
  • Insulin-like growth factor I
  • Kidney failure

Cite this

Kim, Do Hyoung ; Kim, Tae Young ; Kim, Sun Min ; Yoo, Soo Jeong ; Oh, Dong Jin ; Yu, Suk Hee. / IGF-1 is an independent risk factor for anemia in diabetic pre-dialysis patients. In: Korean Journal of Internal Medicine. 2007 ; Vol. 22, No. 3. pp. 186-191.
@article{e4ccb90feeed40e4be9a2b9016258161,
title = "IGF-1 is an independent risk factor for anemia in diabetic pre-dialysis patients",
abstract = "Background: We investigated whether the presence of diabetes mellitus (DM) was related to the degree of the anemia in predialytic patients with renal failure and what was the most relevant factor for anemia in patients with chronic kidney disease (CKD) from DM (DM-CKD). Methods: Seventy seven patients (47 predialytic patients with long-term type 2 DM (DM-CKD) and 30 predialytic patients whose disease was due to other causes (non DM-CKD)) were enrolled in this study. The blood hemoglobin (Hb) and hematocrit, and the creatinine, ferritin, vitamin B12, folate, iron, LDH, albumin, hs-CRP, intact-PTH, erythropoietin, leptin and Insulin-like growth factor I (IGF-1) levels were measured using standard methods. The estimated GFR was calculated using the abbreviated MDRD equation. Results: The two groups did not significantly differ as to age, gender, the serum creatinine level and the inflammatory status. The Hb level was significantly lower in the DM-CKD patients than that in the non DM-CKD patients (8.5±1.7 g/dL vs 9.6±1.6 g/dL, respectively, p=0.01). The Hb level was significantly lower in the DM-CKD patients who were being treated with ACE inhibitors (the DM-ACE patients) than that in the non DM-CKD patients who were being treated with ACE inhibitors (the non DM-ACE patients) (8.5±1.5 g/dL vs 10.8±1.6 g/dL, respectively, p=0.001). Multiple regression analysis indicated that serum IGF-1 concentration was independently associated with the Hb level (β=0.425, p=0.02) in the DM-CKD patients. Conclusions: The Hb concentration was significantly lower in the DM-CKD patients than that in the non DM-CKD patients. It was independently associated with the serum IGF-1 concentration in the DM-CKD patients.",
keywords = "ACE inhibitor, Anemia, Diabetes mellitus, Insulin-like growth factor I, Kidney failure",
author = "Kim, {Do Hyoung} and Kim, {Tae Young} and Kim, {Sun Min} and Yoo, {Soo Jeong} and Oh, {Dong Jin} and Yu, {Suk Hee}",
year = "2007",
month = "1",
day = "1",
doi = "10.3904/kjim.2007.22.3.186",
language = "English",
volume = "22",
pages = "186--191",
journal = "Korean Journal of Internal Medicine",
issn = "1226-3303",
number = "3",

}

IGF-1 is an independent risk factor for anemia in diabetic pre-dialysis patients. / Kim, Do Hyoung; Kim, Tae Young; Kim, Sun Min; Yoo, Soo Jeong; Oh, Dong Jin; Yu, Suk Hee.

In: Korean Journal of Internal Medicine, Vol. 22, No. 3, 01.01.2007, p. 186-191.

Research output: Contribution to journalArticle

TY - JOUR

T1 - IGF-1 is an independent risk factor for anemia in diabetic pre-dialysis patients

AU - Kim, Do Hyoung

AU - Kim, Tae Young

AU - Kim, Sun Min

AU - Yoo, Soo Jeong

AU - Oh, Dong Jin

AU - Yu, Suk Hee

PY - 2007/1/1

Y1 - 2007/1/1

N2 - Background: We investigated whether the presence of diabetes mellitus (DM) was related to the degree of the anemia in predialytic patients with renal failure and what was the most relevant factor for anemia in patients with chronic kidney disease (CKD) from DM (DM-CKD). Methods: Seventy seven patients (47 predialytic patients with long-term type 2 DM (DM-CKD) and 30 predialytic patients whose disease was due to other causes (non DM-CKD)) were enrolled in this study. The blood hemoglobin (Hb) and hematocrit, and the creatinine, ferritin, vitamin B12, folate, iron, LDH, albumin, hs-CRP, intact-PTH, erythropoietin, leptin and Insulin-like growth factor I (IGF-1) levels were measured using standard methods. The estimated GFR was calculated using the abbreviated MDRD equation. Results: The two groups did not significantly differ as to age, gender, the serum creatinine level and the inflammatory status. The Hb level was significantly lower in the DM-CKD patients than that in the non DM-CKD patients (8.5±1.7 g/dL vs 9.6±1.6 g/dL, respectively, p=0.01). The Hb level was significantly lower in the DM-CKD patients who were being treated with ACE inhibitors (the DM-ACE patients) than that in the non DM-CKD patients who were being treated with ACE inhibitors (the non DM-ACE patients) (8.5±1.5 g/dL vs 10.8±1.6 g/dL, respectively, p=0.001). Multiple regression analysis indicated that serum IGF-1 concentration was independently associated with the Hb level (β=0.425, p=0.02) in the DM-CKD patients. Conclusions: The Hb concentration was significantly lower in the DM-CKD patients than that in the non DM-CKD patients. It was independently associated with the serum IGF-1 concentration in the DM-CKD patients.

AB - Background: We investigated whether the presence of diabetes mellitus (DM) was related to the degree of the anemia in predialytic patients with renal failure and what was the most relevant factor for anemia in patients with chronic kidney disease (CKD) from DM (DM-CKD). Methods: Seventy seven patients (47 predialytic patients with long-term type 2 DM (DM-CKD) and 30 predialytic patients whose disease was due to other causes (non DM-CKD)) were enrolled in this study. The blood hemoglobin (Hb) and hematocrit, and the creatinine, ferritin, vitamin B12, folate, iron, LDH, albumin, hs-CRP, intact-PTH, erythropoietin, leptin and Insulin-like growth factor I (IGF-1) levels were measured using standard methods. The estimated GFR was calculated using the abbreviated MDRD equation. Results: The two groups did not significantly differ as to age, gender, the serum creatinine level and the inflammatory status. The Hb level was significantly lower in the DM-CKD patients than that in the non DM-CKD patients (8.5±1.7 g/dL vs 9.6±1.6 g/dL, respectively, p=0.01). The Hb level was significantly lower in the DM-CKD patients who were being treated with ACE inhibitors (the DM-ACE patients) than that in the non DM-CKD patients who were being treated with ACE inhibitors (the non DM-ACE patients) (8.5±1.5 g/dL vs 10.8±1.6 g/dL, respectively, p=0.001). Multiple regression analysis indicated that serum IGF-1 concentration was independently associated with the Hb level (β=0.425, p=0.02) in the DM-CKD patients. Conclusions: The Hb concentration was significantly lower in the DM-CKD patients than that in the non DM-CKD patients. It was independently associated with the serum IGF-1 concentration in the DM-CKD patients.

KW - ACE inhibitor

KW - Anemia

KW - Diabetes mellitus

KW - Insulin-like growth factor I

KW - Kidney failure

UR - http://www.scopus.com/inward/record.url?scp=36549073809&partnerID=8YFLogxK

U2 - 10.3904/kjim.2007.22.3.186

DO - 10.3904/kjim.2007.22.3.186

M3 - Article

C2 - 17939336

AN - SCOPUS:36549073809

VL - 22

SP - 186

EP - 191

JO - Korean Journal of Internal Medicine

JF - Korean Journal of Internal Medicine

SN - 1226-3303

IS - 3

ER -